BML Investment Partners L.P. 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 10:15 am Purchase |
2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners L.P. | 3,466,684 6.700% |
196,777 (+6.02%) |
Filing |
| 2025-02-14 10:06 am Unchanged |
2024-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners L.P. | 3,269,907 6.300% |
0 (Unchanged) |
Filing |
| 2024-12-12 12:29 pm Purchase |
2024-12-06 | 13G | PMV Pharmaceuticals, Inc. PMVP |
BML Investment Partners L.P. | 3,269,907 6.300% |
3,269,907 (New Position) |
Filing |